Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-14-053100

Director sold 1,360,000 shares at an average $0.24 ($328,276)

  • Director acquired 3,106,988 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gunton James T. Director 2014-08-18 Conversion +3,106,988 3,106,988 I
Gunton James T. Director 2014-08-26 Sale −1,000,000 $0.24 $240,400 2,106,988 I
Gunton James T. Director 2014-08-27 Sale −360,000 $0.24 $87,876 1,746,988 I
Derivatives
Gunton James T. Director 2014-08-18 Conversion · Series B Convertible Preferred Stock −1,124.73 39,091.34 I
Open-market sales · 1,360,000 sh · avg $0.24 · $328,276
Loading xslF345X03/v388002_4.xml…